Fig. 1From: Optimizing prostate cancer accumulating model: combined PI-RADS v2 with prostate specific antigen and its derivative dataROC curves of PI-RADS v2 and model 1–13. ROC curves of PI-RADS v2 and model 1–13 for predicting the presence of PCa (a) and CS PCa (b)Back to article page